Results 231 to 240 of about 3,130,788 (278)
Extreme Value Statistics of Community Detection in Complex Networks with Reduced Network Extremal Ensemble Learning (RenEEL). [PDF]
Ghosh T, Zia RKP, Bassler KE.
europepmc +1 more source
Ketogenic Diet as an Epigenetic Therapy in SETD1B‐Related Epilepsy
ABSTRACT Histone lysine methyltransferases such as SETD1B regulate chromatin structure and gene transcription. Ketone bodies, including butyrate, act as histone deacetylase inhibitors. We report a 4‐year‐old boy with SETD1B‐related absence epilepsy, refractory to conventional medications, who achieved sustained > 90% seizure reduction on the Modified ...
Erica Tsang +10 more
wiley +1 more source
Causal interaction of metabolic oscillations in monolayers of Hela cervical cancer cells: emergence of complex networks. [PDF]
Amemiya T +6 more
europepmc +1 more source
Multidimensional Profiling of MRI‐Negative Temporal Lobe Epilepsy Uncovers Distinct Phenotypes
ABSTRACT Objective Although hippocampal sclerosis (TLE‐HS) represents the most frequent cause of temporal lobe epilepsy (TLE), up to 30% of patients show no lesion on visual MRI inspection (TLE‐MRIneg). These cases pose diagnostic and therapeutic challenges and are underrepresented in surgical series.
Alice Ballerini +28 more
wiley +1 more source
Link prediction of heterogeneous complex networks based on an improved embedding learning algorithm. [PDF]
Chai L, Huang R.
europepmc +1 more source
Epigenetic reprogramming in hematopoietic stem and progenitor cells (HSPCs) and downstream myeloid cells, mediated by H3.3 downregulation and endogenous retroelement (ERE) overexpression, contributes to the progression of multiple sclerosis (MS). ABSTRACT Background Skewed myelopoiesis in the bone marrow has been identified as a key driver of multiple ...
Li‐Mei Xiao +6 more
wiley +1 more source
Non-Fragile Estimation for Nonlinear Delayed Complex Networks with Random Couplings Using Binary Encoding Schemes. [PDF]
Hou N, Li W, Song Y, Chang M, Bu X.
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
Spectral energy transfer on complex networks: a filtering approach. [PDF]
MacMillan T, Ouellette NT.
europepmc +1 more source

